C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 31/70 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2226085
An aortic-preferentially-expressed gene-1 (APEG-1) polypeptide, DNA sequences encoding and controlling the transcription of APEG-1, methods of diagnosing vascular injury, and methods of inhibiting vascular smooth muscle cell proliferation by increasing the level of APEG-1 at the site of vascular injury.
L'invention se rapporte à un polypeptide du gène à expression spécifique des cellules aortiques-1 (APEG-1), à des séquences d'ADN codant et régulant la transcription d'APEG-1, à des procédés de diagnostic de lésions vasculaires et à des procédés d'inhibition de la prolifération cellulaire dans les muscles lisses vasculaires, consistant à augmenter le taux d'APEG-1 sur le site de la lésion vasculaire.
Hsieh Chung-Ming
Lee Mu-En
Kirby Eades Gale Baker
President And Fellows Of Harvard College
LandOfFree
Aortic preferentially-expressed gene and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aortic preferentially-expressed gene and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aortic preferentially-expressed gene and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1923580